— Know what they know.
Not Investment Advice

005690.KS KSC

Pharmicell Co., Ltd.
1W: -1.1% 1M: +13.4% 3M: -8.9% YTD: -16.3% 1Y: -5.8% 3Y: +72.4% 5Y: -30.6%
₩12,400.00 ($9.23)
-190.00 (-1.51%)
 
Weekly Expected Move ±6.9%
₩10694 ₩11547 ₩12400 ₩13253 ₩14106
KSC · Healthcare · Biotechnology · Tech Score Buy · Power 64 · ₩744.0B mcap · 54M float · 1.74% daily turnover

📊 Key Metrics

TTM
₩136B
Revenue
+51.3% YoY
₩47B
Net Income
+124.9% YoY
₩26B
Free Cash Flow
+30.9% YoY
43.4%
Gross Margin
33.8%
Op. Margin
26.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE38.1%
ROA30.5%
ROIC42.3%

Valuation

P/E16.0
P/B5.2
EV/EBITDA15.7

Leverage

Debt/Equity0.18
Current Ratio7.15
Interest Cov.45.0x

Quality Scores

Piotroski F5/9
Altman Z14.07
Beneish M-1.53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms